Company Filing History:
Years Active: 2021-2022
Title: Liyan Yue: Innovator in Autophagy Regulation
Introduction
Liyan Yue is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedicine, particularly in the area of autophagy regulation. With a total of 3 patents to his name, Yue is recognized for his innovative approaches to drug development.
Latest Patents
Yue's latest patents include the use of aminomethylenecyclohexane-1,3-dione compound. This invention relates to the use of a specific compound or its pharmaceutically acceptable salt in preparing a drug for regulating or treating diseases related to autophagy, especially concerning mammalian ATG8 homologous proteins. Another notable patent involves compounds used as autophagy modulators, along with a method for preparing and utilizing these compounds. This patent specifically provides a compound of general formula (I) or its pharmaceutically acceptable salts, which serve as autophagy modulators, particularly for mammalian ATG8 homologues.
Career Highlights
Liyan Yue is currently employed at Wigen Biomedicine Technology (Shanghai) Co., Ltd. His work at this company focuses on advancing biomedicine through innovative research and development. His expertise in autophagy regulation has positioned him as a key player in the field.
Collaborations
Yue collaborates with notable colleagues, including Cheng Luo and Wei Wan. Their combined efforts contribute to the advancement of research in biomedicine and the development of new therapeutic strategies.
Conclusion
Liyan Yue's contributions to the field of autophagy regulation through his patents and work at Wigen Biomedicine Technology highlight his role as an influential inventor. His innovative approaches continue to pave the way for advancements in drug development and treatment strategies.